ZFIN ID: ZDB-FISH-150901-14620
Fish name: WT + MO1-foxc1b + MO2-foxc1a
Genotype: WT
Targeting Reagent: MO2-foxc1a, MO1-foxc1b
HUMAN DISEASE MODELED by WT + MO1-foxc1b + MO2-foxc1a
Human Disease Conditions Citations
cerebrovascular disease standard conditions French et al., 2014
glaucoma standard conditions Skarie et al., 2009
GENE EXPRESSION
Gene expression in WT + MO1-foxc1b + MO2-foxc1a
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab1-lama1 standard conditions Fig. 7 from Skarie et al., 2009
Reporter gene expression No data available
PHENOTYPE
Phenotype in WT + MO1-foxc1b + MO2-foxc1a
Phenotype Conditions Figures
blood circulation disrupted, abnormal standard conditions Fig. 2 from Skarie et al., 2009
brain hemorrhagic, abnormal standard conditions Fig. 1Fig. 2 from French et al., 2014
brain hydrocephalic, abnormal standard conditions Fig. 2Fig. 8 from Skarie et al., 2009
brain hydrocephalic, abnormal chemical treatment: N-phenylthiourea Fig. 7 from Acharya et al., 2011
brain vasculature morphology, abnormal standard conditions Fig. S2 from French et al., 2014
central nervous system hemorrhagic, abnormal standard conditions Fig. 2Fig. 8 from Skarie et al., 2009
corneal endothelium aplastic, abnormal standard conditions Fig. 3 from Skarie et al., 2009
corneal stroma structure, abnormal standard conditions Fig. 3 from Skarie et al., 2009
eye apoptotic, abnormal standard conditions Fig. 7 from Berry et al., 2008
eye decreased size, abnormal standard conditions Fig. 2Fig. 3 from Skarie et al., 2009
eye hemorrhagic, abnormal standard conditions Fig. 2Fig. 8 from Skarie et al., 2009
eye hemorrhagic, abnormal chemical treatment: N-phenylthiourea Fig. 7 from Acharya et al., 2011
eye basement membrane disorganized, abnormal standard conditions Fig. 6 from Skarie et al., 2009
eye basement membrane morphology, abnormal standard conditions Fig. 7 from Skarie et al., 2009
hyaloid vessel decreased amount, abnormal standard conditions Fig. 3 from Skarie et al., 2009
hyaloid vessel dilated, abnormal standard conditions Fig. 3 from Skarie et al., 2009
hyaloid vessel morphology, abnormal standard conditions Fig. 6 from Skarie et al., 2009
lens development in camera-type eye delayed, abnormal standard conditions Fig. 3 from Skarie et al., 2009
neural crest cell migration delayed, abnormal standard conditions Fig. S4 from French et al., 2014
pericardium edematous, abnormal standard conditions Fig. 2 from Skarie et al., 2009
periocular mesenchyme disorganized, abnormal standard conditions Fig. 3 from Skarie et al., 2009
retina layer formation delayed, abnormal standard conditions Fig. 3 from Skarie et al., 2009
ventricular system distended, abnormal standard conditions Fig. 3 from Skarie et al., 2009
whole organism decreased length, abnormal chemical treatment: N-phenylthiourea Fig. 7 from Acharya et al., 2011

CITATIONS  (6)